Cleveland’s RSB Spine announced a 131% sales increase for the second quarter of 2011 versus second quarter 2010, and a 20% increase sequentially. These record results represent the seventh consecutive sequential period of quarterly growth for the company.

InterPlate spinal implant

RSB Spine is a privately-held medical device company focused on developing unique modular fusion products for surgical treatment of degenerative disc disease.

RSB Spine CEO John A. Redmond said, “Our performance this quarter is especially gratifying given the challenges facing the spinal implant market, with price erosion and reimbursement pushback from insurance companies. It is a testament to our superior product offering and distribution.”

View the full press release on RSB Spine’s web site.